Annual report pursuant to Section 13 and 15(d)

Acquisition - Schedule of Intangible Assets Acquired (Details)

v3.8.0.1
Acquisition - Schedule of Intangible Assets Acquired (Details) - TRx
Nov. 17, 2017
USD ($)
Business Acquisition [Line Items]  
Identifiable intangible assets $ 18,068,000
PAI Sales & Marketing Agreement  
Business Acquisition [Line Items]  
Identifiable intangible assets 2,334,000
Metafolin | Acquired product marketing rights  
Business Acquisition [Line Items]  
Identifiable intangible assets 10,465,000
Millipred | Acquired product marketing rights  
Business Acquisition [Line Items]  
Identifiable intangible assets 4,714,000
Ulesfia | Acquired product marketing rights  
Business Acquisition [Line Items]  
Identifiable intangible assets $ 555,000